Investor Update
Basel 9 November 2009
Anti-Malignancy Agent Avastin Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer
Dear Investor,
Please find attached a press release issued by Chugai in Japan
Basel 9 November 2009
Dear Investor,
Please find attached a press release issued by Chugai in Japan